TrialAlimentary pharmacology & therapeutics2026

Rifaximin Improves Cognitive Performance and Reduces Cirrhosis-Related Adverse Events in Covert Hepatic Encephalopathy: A Randomized Controlled Trial.

Hiroki Inada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.